Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Alvarez

Showing results (331-340 of 703) with videos related to

Pageof 71
Sort By:
Gene|February 11, 2019
Spectrum of clinical heterogeneity of β-tubulin TUBB5 gene mutationsI Madrigal, R Rabionet, M I Alvarez-Mora, et al.
Research in Veterinary Science|May 20, 1999
Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministrationG Merino, A I Alvarez, P A Redondo, et al.
Biochemistry|August 22, 2001
On the multiple functional roles of the active site histidine in catalysis and allosteric regulation of Escherichia coli glucosamine 6-phosphate deaminaseG M Montero-Morán, S Lara-González, L I Alvarez-Añorve, et al.
Parasitology|October 16, 2010
Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Parasitology Research|August 23, 2011
Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1993
Prevalence of anti-HTLV-I antibodies in HIV-seropositive individuals in Guadalajara, MexicoE Vazquez-Valls, P I Campos-Lopez, B M Torres-Mendoza, et al.
Parasitology|December 23, 2009
Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazoleC Devine, G P Brennan, C E Lanusse, et al.
Parasitology|December 17, 2008
Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 1999
Presystemic metabolism of albendazole: experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumenP A Redondo, A I Alvarez, J L Garcia, et al.
The Journal of Pharmacy and Pharmacology|July 5, 2003
Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazoleG Merino, A J Molina, J L García, et al.
Pageof 71

Showing results (331-340 of 703) with videos related to

Sort By:
Pageof 71
Gene|February 11, 2019
Spectrum of clinical heterogeneity of β-tubulin TUBB5 gene mutationsI Madrigal, R Rabionet, M I Alvarez-Mora, et al.
Research in Veterinary Science|May 20, 1999
Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministrationG Merino, A I Alvarez, P A Redondo, et al.
Biochemistry|August 22, 2001
On the multiple functional roles of the active site histidine in catalysis and allosteric regulation of Escherichia coli glucosamine 6-phosphate deaminaseG M Montero-Morán, S Lara-González, L I Alvarez-Añorve, et al.
Parasitology|October 16, 2010
Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Parasitology Research|August 23, 2011
Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1993
Prevalence of anti-HTLV-I antibodies in HIV-seropositive individuals in Guadalajara, MexicoE Vazquez-Valls, P I Campos-Lopez, B M Torres-Mendoza, et al.
Parasitology|December 23, 2009
Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazoleC Devine, G P Brennan, C E Lanusse, et al.
Parasitology|December 17, 2008
Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 1999
Presystemic metabolism of albendazole: experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumenP A Redondo, A I Alvarez, J L Garcia, et al.
The Journal of Pharmacy and Pharmacology|July 5, 2003
Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazoleG Merino, A J Molina, J L García, et al.
Pageof 71